Intralymphatic histiocytosis of the upper eyelid in a patient of Korean descent: A case report.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
10 Nov 2023
10 Nov 2023
Historique:
medline:
15
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
ppublish
Résumé
Diagnosing intralymphatic histiocytosis can be challenging due to its rarity. We present a case of intralymphatic histiocytosis in the upper eyelid of a Korean patient. We treated the condition by surgical debulking and intralesional triamcinolone injection. A 59-year-old man was referred to our clinic with a 7-year history of unilateral swelling in the right upper eyelid. He had previously been treated with long-term oral steroids and immunosuppressants, but his eyelid swelling persisted. Unilaterally non-pitting erythematous edema was localized on the right upper eyelid without any itching or pain. His best corrected visual acuity at presentation was 20/20 for both eyes. Enhanced orbital computerized tomography revealed edematous soft tissue thickening in the right upper eyelid. In the laboratory testing, the erythrocyte sedimentation rate showed an increase of 19, and the antinuclear antibody titer was positive with a homogeneous pattern. We diagnosed the patient with intralymphatic histiocytosis based on the histopathological findings. We attempted surgical debulking and biopsy on the right upper eyelid due to the persistent symptoms and the absence of a definitive diagnosis. The patient has demonstrated significant improvement after receiving an intralesional triamcinolone injection in the right upper eyelid following the surgery and is currently under follow-up with no signs of recurrence. Ophthalmologists should consider intralymphatic histiocytosis in cases of persistent eyelid swelling that do not respond to treatment, even in Asian patients. Surgical debulking and intralesional triamcinolone injections may be beneficial for improvement.
Identifiants
pubmed: 37960726
doi: 10.1097/MD.0000000000036035
pii: 00005792-202311100-00013
pmc: PMC10637409
doi:
Substances chimiques
Triamcinolone
1ZK20VI6TY
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e36035Informations de copyright
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Clin Exp Dermatol. 2008 Nov;33(6):764-7
pubmed: 18627384
Postepy Dermatol Alergol. 2021 Jun;38(3):533-536
pubmed: 34377141
Ophthalmic Plast Reconstr Surg. 2005 May;21(3):243-5
pubmed: 15942506
Am J Dermatopathol. 2020 Jun;42(6):452-454
pubmed: 31764086
Dermatol Reports. 2021 Aug 05;14(2):9270
pubmed: 35795832
Dermatol Clin. 1996 Apr;14(2):371-9
pubmed: 8725591
Histopathology. 1994 Mar;24(3):265-8
pubmed: 8200627
J Cutan Pathol. 2015 Sep;42(9):593-9
pubmed: 26375955
J Dermatol. 1997 May;24(5):281-96
pubmed: 9198316
Am J Dermatopathol. 2009 Apr;31(2):140-51
pubmed: 19318799
Case Rep Dermatol. 2021 Jan 7;13(1):1-6
pubmed: 33613226
Ann Dermatol. 2022 Jun;34(3):225-227
pubmed: 35721336
Am J Dermatopathol. 2015 Oct;37(10):783-9
pubmed: 26359822